Danaher Co. (NYSE:DHR) Shares Purchased by Hudson Value Partners LLC

Hudson Value Partners LLC grew its holdings in Danaher Co. (NYSE:DHR) by 1.5% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 23,477 shares of the conglomerate’s stock after buying an additional 349 shares during the period. Danaher accounts for approximately 2.5% of Hudson Value Partners LLC’s portfolio, making the stock its 8th largest position. Hudson Value Partners LLC’s holdings in Danaher were worth $6,527,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norden Group LLC acquired a new position in Danaher during the first quarter worth $276,000. Envestnet Portfolio Solutions Inc. increased its holdings in shares of Danaher by 18.6% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 71,432 shares of the conglomerate’s stock valued at $17,838,000 after purchasing an additional 11,221 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Danaher by 84.1% in the first quarter. Empowered Funds LLC now owns 15,179 shares of the conglomerate’s stock valued at $3,790,000 after purchasing an additional 6,932 shares during the period. Hilltop National Bank acquired a new position in Danaher during the first quarter worth about $344,000. Finally, Obermeyer Wood Investment Counsel Lllp acquired a new stake in shares of Danaher during the 1st quarter valued at approximately $286,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Danaher stock opened at $246.10 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a one year low of $192.35 and a one year high of $281.70. The stock’s 50 day moving average price is $265.79 and its 200 day moving average price is $260.75. The firm has a market capitalization of $177.75 billion, a PE ratio of 46.97, a price-to-earnings-growth ratio of 4.54 and a beta of 0.85.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.02 EPS. As a group, sell-side analysts expect that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on DHR shares. Royal Bank of Canada cut their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Robert W. Baird lowered their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Bank of America upped their price objective on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Raymond James dropped their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Finally, Leerink Partners raised their price target on shares of Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Insider Buying and Selling at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 10.90% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.